(BN) *VALEANT RAISES CASH PORTION OF ALLERGAN OFFER 21% TO $58.30/SHR

PRN 05/28 10:00 Valeant Substantially Increases Merger Proposal For Allergan
BN 05/28 10:04 *VRX TO WORK WITH ALLERGAN'S BOARD TO FINALIZE DETAILS OF CVR
BFW 05/28 10:03 *CORRECT: VALEANT BOOSTS CASH PORTION OF ALLERGAN OFFER 21%
BN 05/28 10:03 *CORRECT: VALEANT BOOSTS CASH PORTION OF ALLERGAN OFFER 21%
BN 05/28 10:03 *VRX MAINTAINS 0.83 OF A VALEANT SHARE AS PART OF DEAL
BN 05/28 10:02 *VALEANT RAISES CASH PORTION OF ALLERGAN OFFER 21% TO $58.30/SHR
BN 05/28 10:02 *VRX ADDS CONTINGENT VALUE RIGHT FOR DARPIN OF UP TO $25/SHR
BN 05/28 10:00 *VALEANT ADDS CONTINGENT VALUE RIGHT DARPIN UP TO $25.00/SHR
BN 05/28 10:00 *VALEANT COMMITS TO INVEST UP TO $400M IN DARPIN
BN 05/28 10:00 *VALEANT BOOSTS MERGER PROPOSAL BY $10/SHR TO $58.30
BN 05/28 10:00 *VALEANT BOOSTS MERGER PROPOSAL FOR ALLERGAN TO $58.30
BN 05/28 10:00 *VALEANT BOOSTS MERGER PROPOSAL FOR ALLERGAN BY $10.00/SHR
BN 05/28 10:00 *VALEANT SUBSTANTIALLY INCREASES MERGER PROPOSAL FOR ALLERGAN

Valeant Boosts Cash Part of Allergan Bid by $10/Shr to $58.30
2014-05-28 10:03:02.167 GMT

By Colleen McElroy
     May 28 (Bloomberg) -- Commits to invest up to $400m in
Darpin.
  * NOTE: April 22 Valeant Offers $48.30 Cash, 0.83 Shrs for
    Allergan {NSN N4FKLX6KLVRH<Go>}

Link to Statement:{NSN N6A3S33MSFLS <GO>}
Link to Company News:{AGN US <Equity> CN <GO>}
Link to Company News:{VRX CN <Equity> CN <GO>}

For Related News and Information:
First Word scrolling panel: {FIRST<GO>}
First Word newswire: {NH BFW<GO>}

To contact the editor responsible for this story:
Colleen McElroy at +1-212-617-5057 or
cmcelroy@bloomberg.net